These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19928497)

  • 1. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laboratory examinations in antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical diagnosis of thrombosis and blood coagulation tests].
    Watanabe K
    Rinsho Byori; 1998 Mar; 46(3):235-44. PubMed ID: 9564763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
    Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
    Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant syndrome: case report.
    Mwanda OW
    East Afr Med J; 1998 Oct; 75(10):619-20. PubMed ID: 10065201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
    Robert A
    Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
    Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
    Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM; Marlar RA
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
    Triplett DA
    Clin Lab Sci; 1997; 10(4):223-8. PubMed ID: 10169622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on usefulness of different APTT test kit in variable coagulopathy].
    Naito S; Ieko M; Yoshida M; Tarumi T; Nakabayashi T; Nishio H; Atsumi T
    Rinsho Byori; 2008 Mar; 56(3):195-202. PubMed ID: 18411803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
    Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
    Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lupus anticoagulant neutralization procedure using the patient's own platelets.
    Carroll P; Ray M; Just S; Hawson G
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].
    Morinaga S; Ide Y; Kusumoto M; Ogata M; Takaki K; Matsumoto E
    Rinsho Ketsueki; 2012 Jul; 53(7):716-20. PubMed ID: 22975775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.